openPR Logo

Press Releases from SIMFO Spezielle Immunologie Forschung + Entwicklung GmbH (3 total)

SIMFO to present maintrac liquid biopsy at the BIO International Convention 2017

Maintrac Liquid Biopsy recognized by the European Commission as one of the most innovative procedures in circulating tumor cells As one of the 15 most innovative European companies SIMFO GmbH was invited by the European Commission to the Bio International Convention (BIO) 2017 to present maintrac® liquid biopsy under the patronage of the EU. Small and medium-sized enterprises are given the opportunity to obtain comprehensive information about the US healthcare and

maintrac® launches Immunotherapy PDL-1 blood test

Immunotherapy was one of the big topics at ASCO (American Society of Clinical Oncology) this year. Because of its potential, ASCO named it "The 2016 Clinical Cancer Advance of the Year". Immunotherapy is among today’s most promising approaches to improving the outcomes of patients. Obtaining PD-L1 status previously required an invasive tissue biopsy. The highest quality liquid biopsy maintrac ® now makes an invasive procedure obsolete. A simple blood test, the

Pretreatment testing of SIMFO anticancer drug on patient blood

Dubai / Bayreuth - At the 2nd World Conference for Drug Discovery and Therapy, Prof. Dr. Katharina Pachmann (Jena University) presented a worldwide unique approach in oncology that can detect circulating tumor cells in the blood of cancer patients. After tumor removal, any remaining, washed out tumor cells are responsible for the development of metastases, which shorten survival time in most patients. A good, often metastasis-free prognosis of survival is achieved

Go To Page:   1 2 3 4 5 6 7 8 9 10